Literature DB >> 16713519

Period estimates of cancer patient survival are more up-to-date than complete estimates even at comparable levels of precision.

Hermann Brenner1, Timo Hakulinen.   

Abstract

BACKGROUND AND
OBJECTIVE: Period analysis provides more up-to-date estimates of cancer patient survival than traditional methods, but there is a trade-off between up-to-dateness and precision. Our objective was to compare the performance of period and complete analysis in terms of up-to-dateness and precision of survival estimates. STUDY DESIGN AND
SETTING: Five-year relative survival data actually observed for patients diagnosed with 1 of 20 common forms of cancer in Finland in 36 overlapping 5-year periods between 1958-1962 and 1993-1997 were compared with period estimates and various variants of complete estimates of 5-year relative survival potentially available during these periods.
RESULTS: At comparable levels of up-to-dateness, survival estimates from period analysis were more precise than survival estimates from complete analysis. At comparable levels of precision, period analysis provided more up-to-date survival estimates than did complete analysis.
CONCLUSION: These results further encourage more widespread use of period analysis as a standard tool for up-to-date monitoring of cancer patient survival by population-based cancer registries.

Entities:  

Mesh:

Year:  2006        PMID: 16713519     DOI: 10.1016/j.jclinepi.2005.10.012

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  Disparate survival trends in histologic subtypes of metastatic non-small cell lung cancer: a population-based analysis.

Authors:  Adam J Olszewski; Shihab Ali; Sabrina M Witherby
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

2.  Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider.

Authors:  Haim A Abenhaim; Linda Titus-Ernstoff; Daniel W Cramer
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

3.  Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.

Authors:  Adam J Olszewski; Steven P Treon; Jorge J Castillo
Journal:  Oncologist       Date:  2016-07-29

4.  Robustness of individual and marginal model-based estimates: A sensitivity analysis of flexible parametric models.

Authors:  Elisavet Syriopoulou; Sarwar I Mozumder; Mark J Rutherford; Paul C Lambert
Journal:  Cancer Epidemiol       Date:  2018-11-12       Impact factor: 2.984

5.  Understanding the impact of socioeconomic differences in colorectal cancer survival: potential gain in life-years.

Authors:  Elisavet Syriopoulou; Eva Morris; Paul J Finan; Paul C Lambert; Mark J Rutherford
Journal:  Br J Cancer       Date:  2019-05-01       Impact factor: 7.640

6.  Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England.

Authors:  Elisavet Syriopoulou; Hannah Bower; Therese M-L Andersson; Paul C Lambert; Mark J Rutherford
Journal:  Br J Cancer       Date:  2017-09-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.